Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations

Funding for the mhGAP Programme, under which the work reported in this manuscript was done, was by the following: American Psychiatric Foundation, USA; Association of Aichi Psychiatric Hospitals, Japan; Speaks, USA; CBM; Government of Italy; Government of Japan; Government of The Netherlands; Bureau for Epilepsy; International League Against Epilepsy; Medical Research Council, UK; National of Mental Health, USA; Public Health Agency of Canada, Canada; Rockefeller Foundation, USA; Shirley, UK; Syngenta, Switzerland; United Nations Population Fund;World Psychiatric Association